Back to search

Article

The clinical significance of the expression of PROM1/CD133, NOTCH2 and CDK4 in triple-negative breast cancer

2023-12-11

Abstract excerpt

<h4>Purpose: </h4> The aim of this study is to investigate the expression of cyclin kinase 4 (CDK4), PROM1/CD133 (CSC marker), and NOTCH2 proteins in triple negative breast cancer (TNBC), and to determine their correlation with clinicopathological parameters and survival prognosis. Additionally, we aim to explore the prognostic value of co-expression in TNBC. <h4>Method: </h4> In this study, we utilized the GEPIA...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
19600110-ba45-5a49-aa18-b2ebef7b1c12
DOI
10.21203/rs.3.rs-3715135/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The clinical significance of the expression of PROM1/CD133, NOTCH2 and CDK4 in triple-negative breast cancerDOI 10.21203/rs.3.rs-3715135/v1
Select a neighboring publication to make it the new centre.